Literature DB >> 12425311

From the Centers for Disease Control and Prevention. Vancomycin resistant Staphylococcus aureus--Pennsylvania, 2002.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12425311

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.

Authors:  Christine D Hardy; Nicholas R Cozzarelli
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

2.  Antibacterial activity of REP8839, a new antibiotic for topical use.

Authors:  Ian A Critchley; Casey L Young; Kimberley C Stone; Urs A Ochsner; Joseph Guiles; Ted Tarasow; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.

Authors:  Michael J Pucci; Jijun Cheng; Steven D Podos; Christy L Thoma; Jane A Thanassi; Douglas D Buechter; Gohar Mushtaq; Gerald A Vigliotti; Barton J Bradbury; Milind Deshpande
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

4.  In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.

Authors:  Michael J Pucci; Steven D Podos; Jane A Thanassi; Melissa J Leggio; Barton J Bradbury; Milind Deshpande
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

5.  Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus.

Authors:  Hua Xu; Todd J Sullivan; Jun-ichiro Sekiguchi; Teruo Kirikae; Iwao Ojima; Christopher F Stratton; Weimin Mao; Fernando L Rock; M R K Alley; Francis Johnson; Stephen G Walker; Peter J Tonge
Journal:  Biochemistry       Date:  2008-03-13       Impact factor: 3.162

6.  Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.

Authors:  Marilyn Chung; Aude Antignac; Choonkeun Kim; Alexander Tomasz
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

7.  Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization.

Authors:  Jon P Furuno; Eli N Perencevich; Judith A Johnson; Marc-Oliver Wright; Jessina C McGregor; J Glenn Morris; Sandra M Strauss; Mary-Claire Roghman; Lucia L Nemoy; Harold C Standiford; Joan N Hebden; Anthony D Harris
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.